Drug details
Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide fixed-dose combination tablets)
type of HIV, ART Combos
Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide) is a combination of two HIV nucleoside analog reverse transcriptase inhibitors (NRTIs) and a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated as a complete regimen for the treatment of HIV-1 infection in patients 12 years of age and older as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies per mL; or to replace a stable antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) for at least six months with no history of treatment failure and no known substitutions associated with resistance to the individual components of Odefsey.
The drug is often used to treat HIV .
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- loss of appetite,
- dark urine,
- vomiting,
- diarrhea,
- fever,
- swollen glands,
- night sweats,
- shortness of breath,
- weight loss,
- tiredness,
- stomach pain,
- clay-colored stools,
- dizziness,
- wheezing,
- weakness,
- cough,
- restlessness,
- little or no urination,
- mood changes,
- menstrual changes, and
- mouth sores,
- swelling in your feet or ankles,
- right-sided upper stomach pain,
- anxiety,
- depression,
- feeling cold,
- unusual bruising,
- eye redness,
- yellowing of the skin or eyes,
- cold sores,
- problems with balance or eye movement,
- swelling in your neck or throat (enlarged thyroid),
- impotence
- unusual muscle pain,
- prickly feeling,
- irregular heart rate,
- blistering skin rash,
- trouble breathing or swallowing,
- suicidal thoughts or actions,
The following drugs are related to Odefsey, either as a replacement or used together:
- Ziagen (abacavir sulfate)
- Reyataz (atazanavir sulfate)
- Cabenuva (cabotegravir; rilpivirine extended-release injectable suspension)
- Vocabria (cabotegravir tablets for oral use)
- Combivir (lamivudine, zidovudine)
- Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate tablets)
- Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir  alafenamide tablets)
- Delstrigo (doravirine, lamivudine, and tenofovir disoproxil fumarate tablets)
- Videx EC (didanosine delayed-release capsules)
- Videx (didanosine pediatric powder for oral solution)
- Migranal (dihydroergotamine mesylate spray)
- Edurant (rilpivirine tablets)
- Truvada (emtricitabine tenofovir df)
- Epivir (lamivudine)
- Epivir-HBV (lamivudine tablets and oral solution)
- Norvir (ritonavir capsules, oral solution)
- Norvir Soft Gelatin Capsules (ritonavir)
- Viread (tenofovir disoproxil fumarate)